ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF
申请人:AMARI Gabriele
公开号:US20120276018A1
公开(公告)日:2012-11-01
Compounds according to formula (I) are effective for the treatment of broncho-obstructive and inflammatory diseases.
根据公式(I)的化合物对治疗支气管阻塞和炎症性疾病有效。
[EN] ALKALOID ESTER AND CARBAMATE DERIVATIVES AND MEDICINAL COMPOSITIONS THEREOF<br/>[FR] DÉRIVÉS D'ALCALOÏDE ESTER ET CARBAMATE, ET COMPOSITIONS MÉDICINALES À BASE DE CEUX-CI
申请人:CHIESI FARMA SPA
公开号:WO2012146515A1
公开(公告)日:2012-11-01
The present invention relates to compounds acting as muscarinic receptor antagonists, to methods of preparing such derivatives, to compositions comprising them and therapeutic use thereof.
本发明涉及作为毒蕈碱受体拮抗剂的化合物,制造此类衍生物的方法,包含它们的组合物以及它们的治疗用途。
[EN] FUSED TRICYCLIC PYRIDAZINONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS<br/>[FR] COMPOSÉS TRICYCLIQUES FUSIONNÉS DE PYRIDAZINONE UTILES POUR TRAITER DES INFECTIONS À ORTHOMYXOVIRUS
申请人:NOVARTIS AG
公开号:WO2018042303A1
公开(公告)日:2018-03-08
The invention provides compounds of Formula (I): (I) as further described herein, as well as pharmaceutical compositions comprising such compounds, and methods to use the compounds and pharmaceutical compositions for treatment of certain viral disorders, including influenza.
A novel palladium-catalyzed coupling reaction of an arylmethylketone with two molecules of an aryl halide to yield symmetric diarylmethanes is described. In the facile one-pot reaction, the arylmethylketone acts as a formal methylene donor. The experimental facts, including TLC monitoring, speculated intermediates as the raw materials, analysis of the cesium benzoate coproduct by ex situ IR spectroscopy
NOVEL IMIDAZOLYLALKYLCARBONYL DERIVATIVES AS CALCIUM CHANNEL MODULATORS AND PREPARATION METHOD THEREOF
申请人:CHOI Kyung Il
公开号:US20090325979A1
公开(公告)日:2009-12-31
Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.